These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 14694033)

  • 1. Profile of cognitive progression in early Huntington's disease.
    Ho AK; Sahakian BJ; Brown RG; Barker RA; Hodges JR; Ané MN; Snowden J; Thompson J; Esmonde T; Gentry R; Moore JW; Bodner T;
    Neurology; 2003 Dec; 61(12):1702-6. PubMed ID: 14694033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD.
    Bachoud-Lévi AC; Maison P; Bartolomeo P; Boissé MF; Dalla Barba G; Ergis AM; Baudic S; Degos JD; Cesaro P; Peschanski M
    Neurology; 2001 Apr; 56(8):1052-8. PubMed ID: 11320178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.
    Lemiere J; Decruyenaere M; Evers-Kiebooms G; Vandenbussche E; Dom R
    J Neurol; 2004 Aug; 251(8):935-42. PubMed ID: 15316797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HD-CAB: a cognitive assessment battery for clinical trials in Huntington's disease 1,2,3.
    Stout JC; Queller S; Baker KN; Cowlishaw S; Sampaio C; Fitzer-Attas C; Borowsky B;
    Mov Disord; 2014 Sep; 29(10):1281-8. PubMed ID: 25209258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.
    Hart EP; Dumas EM; Giltay EJ; Middelkoop HA; Roos RA
    J Huntingtons Dis; 2013; 2(2):137-47. PubMed ID: 25063511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for specific cognitive deficits in preclinical Huntington's disease.
    Lawrence AD; Hodges JR; Rosser AE; Kershaw A; ffrench-Constant C; Rubinsztein DC; Robbins TW; Sahakian BJ
    Brain; 1998 Jul; 121 ( Pt 7)():1329-41. PubMed ID: 9679784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Beglinger LJ; Duff K; Allison J; Theriault D; O'Rourke JJ; Leserman A; Paulsen JS
    J Clin Exp Neuropsychol; 2010 Jul; 32(6):573-8. PubMed ID: 19882420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of depression on working memory in presymptomatic Huntington's disease.
    Nehl C; Ready RE; Hamilton J; Paulsen JS
    J Neuropsychiatry Clin Neurosci; 2001; 13(3):342-6. PubMed ID: 11514640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive signs in prodromal Huntington disease.
    Stout JC; Paulsen JS; Queller S; Solomon AC; Whitlock KB; Campbell JC; Carlozzi N; Duff K; Beglinger LJ; Langbehn DR; Johnson SA; Biglan KM; Aylward EH
    Neuropsychology; 2011 Jan; 25(1):1-14. PubMed ID: 20919768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal dysfunction defines disease onset in Huntington's disease.
    Begeti F; Schwab LC; Mason SL; Barker RA
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):975-81. PubMed ID: 26833174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J
    Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychometric study in Huntington disease].
    Pasquier F; Cabaret M; Petit H
    Encephale; 1993; 19(4):303-11. PubMed ID: 8275917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive assessment of asymptomatic Huntington's disease carriers].
    Gómez-Tortosa E; del Barrio Alba A; Sánchez Pernaute R; Benítez J; Barroso A; García Yébenes J
    Neurologia; 1997; 12(6):226-31. PubMed ID: 9303588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease.
    Gluhm S; Goldstein J; Brown D; Van Liew C; Gilbert PE; Corey-Bloom J
    Mov Disord; 2013 Oct; 28(12):1744-7. PubMed ID: 23798501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Executive dysfunction in Huntington's disease].
    Redondo Vergé L; Brown RG; Chacón J
    Rev Neurol; 2001 May 16-31; 32(10):923-9. PubMed ID: 11424047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of cognitive disorder in Huntington's disease.
    Snowden J; Craufurd D; Griffiths H; Thompson J; Neary D
    J Int Neuropsychol Soc; 2001 Jan; 7(1):33-44. PubMed ID: 11253840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
    Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of False Memory in Patients with Huntington's Disease.
    Chen IW; Chen CM; Wu YR; Hua MS
    Arch Clin Neuropsychol; 2017 Jun; 32(4):391-400. PubMed ID: 28334378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.